Study on Savolitinib Combined With Osimertinib in Treatment of Advanced NSCLC With MET Amplification
Clinical trial NCT05015608 · COMPLETED
Trial details
- NCT number
- NCT05015608
- Sponsor
- Hutchison Medipharma Limited
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-11-22
- Primary completion
- 2025-08-22
- Enrollment
- 216
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.